Sept. 2015: R00 proposal has been funded by the NIH (NCI)
The Sohl lab has received grant funding for understanding the molecular mechanisms of isocitrate dehydrogenase (IDH) mutations in cancer from the NIH (R00). We are appreciative to the NCI for valuing our research efforts.